Genetic Technologies Announces Independent Clinical Validation Study in Support of the Utilization of BREVAGen™.This independent study, which was conducted under the supervision of Prof. John Hopper and first-authored by Dr. Gillian Dite from the Centre for Molecular Epidemiology at the University of Melbourne.
www.marketwire.com/press-release/genetic-technologies-announces-independent-clinical-validation-study-support-utilization-asx-gtg-1804783.htm
No comments:
Post a Comment